Reshma P. Shetty, the See remarks of $DNA, sold 13,116 shares of the company on 04-09-2026 for an estimated $83,903. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.7% of their shares of this class of stock. Following this trade, they now own 338,568 shares of this class of $DNA stock.
$DNA Insider Trading Activity
$DNA insiders have traded $DNA stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $DNA stock by insiders over the last 6 months:
- JASON R KELLY (See remarks) has made 0 purchases and 2 sales selling 206,782 shares for an estimated $1,374,493.
- RESHMA P. SHETTY (See remarks) has made 0 purchases and 2 sales selling 26,271 shares for an estimated $175,067.
- BARRY CANTON has made 0 purchases and 2 sales selling 26,271 shares for an estimated $175,067.
- STEVEN P. COEN (See remarks) has made 0 purchases and 4 sales selling 3,728 shares for an estimated $37,883.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DNA Hedge Fund Activity
We have seen 77 institutional investors add shares of $DNA stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 843,605 shares (-26.1%) from their portfolio in Q4 2025, for an estimated $7,010,357
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. added 541,845 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,502,731
- BANK OF AMERICA CORP /DE/ removed 465,999 shares (-43.6%) from their portfolio in Q4 2025, for an estimated $3,872,451
- MORGAN STANLEY added 445,765 shares (+139.0%) to their portfolio in Q4 2025, for an estimated $3,704,307
- VANGUARD GROUP INC added 420,448 shares (+17.0%) to their portfolio in Q4 2025, for an estimated $3,493,922
- STATE STREET CORP added 358,231 shares (+38.4%) to their portfolio in Q4 2025, for an estimated $2,976,899
- ALLIANZ ASSET MANAGEMENT GMBH added 257,628 shares (+134.1%) to their portfolio in Q4 2025, for an estimated $2,140,888
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DNA Revenue
$DNA had revenues of $33.4M in Q4 2025. This is a decrease of -462.06% from the same period in the prior year.
You can track DNA financials on Quiver Quantitative's DNA stock page.
$DNA Price Targets
Multiple analysts have issued price targets for $DNA recently. We have seen 2 analysts offer price targets for $DNA in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $5.0 on 03/12/2026
- Brendan Smith from TD Cowen set a target price of $12.0 on 01/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
